OpenVSafe by OpenVAERS
Search V-safe

YX2-47335-98334

1 vaccination 1 coded response 7 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
722 / AR
Registered
2021-04-07
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-07
    Registered in v-safe
  2. 2021-04-07
    Dose 1 — Janssen/Johnson & Johnson
  3. 2021-04-07
    Survey response — day 0, dose 1
    MedDRA: No adverse event — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Free text: No
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-04-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Nausea
    Adult check-in
  7. 2021-07-09
    Health check-in — 3 months, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-10-06
    Health check-in — 6 months, dose 1
    Feeling: Good
    Adult check-in
  9. 2022-04-07
    Health check-in — 12 months, dose 1
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-07Janssen/Johnson & Johnson

Free text

Release 7 — day 0, dose 1

2021-04-07

Systemic reaction (other): No

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SRONo adverse event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…